IPO Boutique

MedPace Holdings IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on MedPace Holdings, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
MedPace HoldingsMEDP -
NASDAQ
$20.00-$23.00 $23.00 $28.157 million8/11/2016
Jefferies, Credit Suisse, UBS Investment Bank, Wells Fargo Securities
Co-Manager(s):
Baird, William Blair
Health Care
Filing(s):

Filed 2016-06-24
Terms Added 2016-08-01



MedPace Holdings Quote & Chart - Click for current quote - MEDP

About MedPace Holdings (adapted from MedPace Holdings prospectus):
They are one of the worlds leading clinical contract research organizations, or CROs, by revenue, solely focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "MEDP" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved